Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis Regimen-Reference-Cited by-同舟云学术

Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis Regimen

Published:2018-09-20 Issue:8 Volume:68 Page:1410-1411
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Guglielmetti Lorenzo¹²^ORCID,Sougakoff Wladimir¹²,Maitre Thomas¹²,Brossier Florence¹²,Jarlier Vincent¹²,Robert Jérôme¹²,Veziris Nicolas²³^ORCID,Aubry Alexandra¹²,

Affiliation:

1. APHP, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (CNR-MyRMA), Bactériologie-Hygiène, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix

2. Sorbonne Université, Medecine, Unité 1135, Centre d’immunologie et des Maladies Infectieuses Team E13, CR7 INSERM

3. APHP, CNR-MyRMA, Département de Bactériologie, Hôpitaux Universitaires de l’Est Parisien, Paris, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/8/1410/28272339/ciy808.pdf

Reference12 articles.

1. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study;Bonnet;Int J Tuberc Lung Dis,2016

2. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis;Van Deun;Am J Respir Crit Care Med,2010

3. Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries;Trébucq;Int J Tuberc Lung Dis,2018

4. Eligibility for the shorter multidrug-resistant tuberculosis regimen: ambiguities in the World Health Organization recommendations;Varaine;Am J Respir Crit Care Med,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prise en charge thérapeutique des tuberculoses résistantes;Médecine et Maladies Infectieuses Formation;2022-06

2. Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field;Frontiers in Microbiology;2022-03-24